HOLLY HARRIS: Open Payments
NPI 1851845234 · KENNER, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$743 in 49 payments from 9 companies in 2025. Trend: 2023 $3,280 · 2024 $1,488 · 2025 $743
Food & beverage: $743
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 13 | $201 |
| ABBVIE INC. | 19 | $170 |
| UCB, Inc. | 4 | $106 |
| LEO Pharma Inc. | 5 | $102 |
| Medimetriks Pharmaceuticals, Inc. | 3 | $55 |
| Pacira Pharmaceuticals Incorporated | 2 | $49 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| Verrica Pharmaceuticals Inc. | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
Products named: DUPIXENT, RINVOQ, Bimzelx, ADBRY, Exparel, ANZUPGO, SKYRIZI, BOTOX.
Industry payments across LA — which companies pay providers there.
